Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers.
Eichholz K, Fukazawa Y, Peterson CW, Haeseleer F, Medina M, Hoffmeister S, Duell DM, Varco-Merth BD, Dross S, Park H, Labriola CS, Axthelm MK, Murnane RD, Smedley JV, Jin L, Gong J, Rust BJ, Fuller DH, Kiem HP, Picker LJ, Okoye AA, Corey L.
Eichholz K, et al. Among authors: haeseleer f.
J Clin Invest. 2024 Apr 1;134(7):e169309. doi: 10.1172/JCI169309.
J Clin Invest. 2024.
PMID: 38557496
Free PMC article.